Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging
Clinical trial NCT03938636 · COMPLETED
Trial details
- NCT number
- NCT03938636
- Sponsor
- Navidea Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-08
- Primary completion
- 2021-02-08
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.